ATE385574T1 - Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen - Google Patents

Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen

Info

Publication number
ATE385574T1
ATE385574T1 AT03706157T AT03706157T ATE385574T1 AT E385574 T1 ATE385574 T1 AT E385574T1 AT 03706157 T AT03706157 T AT 03706157T AT 03706157 T AT03706157 T AT 03706157T AT E385574 T1 ATE385574 T1 AT E385574T1
Authority
AT
Austria
Prior art keywords
cell sample
melatonin
signaling pathway
idiopathic scoliosis
related diseases
Prior art date
Application number
AT03706157T
Other languages
English (en)
Inventor
Alain Moreau
Original Assignee
Chu Sainte Justine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu Sainte Justine filed Critical Chu Sainte Justine
Application granted granted Critical
Publication of ATE385574T1 publication Critical patent/ATE385574T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Testing Of Engines (AREA)
  • Saccharide Compounds (AREA)
AT03706157T 2002-02-28 2003-02-28 Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen ATE385574T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002373854A CA2373854A1 (en) 2002-02-28 2002-02-28 Methods of diagnosing and counteracting adolescent idiopathic scoliosis

Publications (1)

Publication Number Publication Date
ATE385574T1 true ATE385574T1 (de) 2008-02-15

Family

ID=27762090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706157T ATE385574T1 (de) 2002-02-28 2003-02-28 Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen

Country Status (11)

Country Link
US (7) US20050130250A1 (de)
EP (1) EP1478928B1 (de)
AT (1) ATE385574T1 (de)
AU (1) AU2003208204A1 (de)
CA (1) CA2373854A1 (de)
CY (1) CY1107358T1 (de)
DE (1) DE60318987T2 (de)
DK (1) DK1478928T3 (de)
ES (1) ES2298498T3 (de)
PT (1) PT1478928E (de)
WO (1) WO2003073102A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373854A1 (en) 2002-02-28 2003-08-28 Alain Moreau Methods of diagnosing and counteracting adolescent idiopathic scoliosis
US20090104620A1 (en) * 2007-07-03 2009-04-23 Axial Biotech, Inc. Simplified Method of Determining Predisposition to Scoliosis
US20090035769A1 (en) * 2007-12-31 2009-02-05 Nelson Lesa M Genetic Markers Associated with Scoliosis and Uses Thereof
US20090035772A1 (en) * 2007-07-03 2009-02-05 Axial Biotech, Inc. Genetic Markers Associated With Scoliosis And Uses Thereof
US7655403B2 (en) * 2006-12-02 2010-02-02 Texas Scottish Rite Hospital For Children CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis
WO2008113174A1 (en) * 2007-03-19 2008-09-25 Chu Sainte-Justine Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
MX2009010400A (es) 2007-03-30 2010-02-18 Chu Sainte Justine Método para la determinacion de riesgo de escoliosis.
TWI443337B (zh) * 2008-10-10 2014-07-01 Ct Hospitalier Universitaire Sainte Justine 用於脊柱側彎之分類及診斷的方法
EP2598875B1 (de) * 2010-10-04 2016-12-07 Chu Sainte-Justine Verfahren zur skoliose-diagnose auf biomechanischer basis
CA2914213A1 (en) 2013-06-17 2014-12-24 Alain Moreau A method of increasing gipcr signalization in the cells of a scoliotic subject
US20160139146A1 (en) 2013-06-17 2016-05-19 Chu Sainte-Justine Gi protein phosphorylation as marker for scoliosis and scoliosis progression, methods of increasing gipcr signaling in scoliotic subjects
WO2014201560A1 (en) 2013-06-17 2014-12-24 Chu Ste-Justine New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis
US10247737B2 (en) 2013-09-09 2019-04-02 Chu Sainte-Justine Kits for classifying a subject having or at risk for developing idiopathic scoliosis
KR102397233B1 (ko) 2014-09-25 2022-05-12 프로제너티, 인크. 위치추정 능력을 갖는 전기기계 알약 장치
CA2989480C (en) 2015-06-16 2024-03-05 Centro De Investigacion Biomedica En Red (Ciber) Kit and method for the diagnosis/prognosis of idiopathic scoliosis
EP3500177A1 (de) * 2016-08-18 2019-06-26 Mitchell Lawrence Jones Systeme zur gewinnung von proben mithilfe einnehmbarer vorrichtungen
JP2019526423A (ja) 2016-09-09 2019-09-19 ミッチェル・ローレンス・ジョーンズMitchell Lawrence JONES 分注可能物質の送達のための電気機械的摂取可能装置
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
KR102329597B1 (ko) 2017-03-31 2021-11-23 프로제너티, 인크. 섭취가능한 디바이스용 측위 시스템 및 방법
EP3883635A1 (de) 2018-11-19 2021-09-29 Progenity, Inc. Verfahren und vorrichtungen zur behandlung einer krankheit mit biotherapeutika
CN111575361A (zh) * 2020-04-20 2020-08-25 孙欣 一种褪黑素通路调控因子治疗ais患者的测试方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856124A (en) * 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
DE69735852D1 (de) * 1996-07-18 2006-06-14 Gen Hospital Corp Regulatorische regionen des gens für den melatonin 1a rezeptor und deren verwendungen
JPH119282A (ja) * 1997-06-19 1999-01-19 Nippon Chem Res Kk メラトニン受容体発現細胞とその用途
AU6385200A (en) * 1999-07-30 2001-02-19 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
CA2373854A1 (en) * 2002-02-28 2003-08-28 Alain Moreau Methods of diagnosing and counteracting adolescent idiopathic scoliosis

Also Published As

Publication number Publication date
EP1478928B1 (de) 2008-02-06
DE60318987T2 (de) 2009-01-29
DE60318987D1 (de) 2008-03-20
US20160258947A1 (en) 2016-09-08
CY1107358T1 (el) 2012-12-19
US20110256582A1 (en) 2011-10-20
EP1478928A1 (de) 2004-11-24
CA2373854A1 (en) 2003-08-28
US20090111110A1 (en) 2009-04-30
US7989175B2 (en) 2011-08-02
WO2003073102A1 (en) 2003-09-04
HK1071601A1 (en) 2005-07-22
DK1478928T3 (da) 2008-05-19
US20140113313A1 (en) 2014-04-24
US20130115615A1 (en) 2013-05-09
ES2298498T3 (es) 2008-05-16
AU2003208204A1 (en) 2003-09-09
US8652791B2 (en) 2014-02-18
PT1478928E (pt) 2008-04-09
US20050130250A1 (en) 2005-06-16
US20120009600A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
ATE385574T1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
CY1109106T1 (el) Εγκαιρη διαγνωση ασθενειων διαταραχης διαμορφωσης πρωτεϊνων
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
EP1563300A4 (de) Diagnoseverfahren für sprue/zeliakie
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
EP2520935A3 (de) Organspezifische Proteine und Verfahren zu deren Verwendung
DE602004026014D1 (de) Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
EP1543331A4 (de) Verfahren zur diagnose von morbus alzheimer
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
EP2508886A3 (de) Mittel und Verfahren zur Klassifizierung von Proben von Multiple-Sklerose-Patienten.
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE403739T1 (de) Verfahren zur verwendung teilungsarretierter zellen in screening-assays
ATA19972000A (de) Pibf für die diagnose von tumoren
SE0200974D0 (sv) Screening method for gastritis
ATE408827T1 (de) Quantifizierung von stressbelastung
ATE550662T1 (de) Diagnose- und behandlungsverfahren sowie dafür geeignete mittel
ATE461452T1 (de) Verfahren zum nachweis von menschlichem parvovirus-antigen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1478928

Country of ref document: EP

REN Ceased due to non-payment of the annual fee